Zoetis targets livestock immunotherapies as alternatives to antibiotics R&D incubator lab at CSU brings livestock health research, jobs to Fort Collins
Zoetis, the world’s leading animal health company, has signed an agreement with Colorado State University (CSU) to establish a research lab at CSU that will explore the livestock immune system and target new immunotherapies – paving the way for new alternatives to antibiotics in food-producing animals. The new 3,000-square-foot Zoetis Incubator Research Lab will operate at the Research Innovation Center on CSU’s Foothills Campus starting in early 2020.
“Our agreement with Zoetis represents the beginning of an era of collaboration, cooperation and innovation between public and private research leaders, all in the interest of improving animal health,” said Ray Goodrich, executive director of the Infectious Disease Research Center and a professor in the Department of Microbiology, Immunology and Pathology at CSU.
Going where the science is
As part of the new lab, Zoetis expects to hire up to 20 livestock research scientists, immunologists and cell biologists in Fort Collins beginning this fall.
“Zoetis is committed to continuous innovation and going where the science is. CSU is at the forefront of infectious disease innovation and animal health research in a vibrant biotech community, making it the ideal environment for our Incubator Research Lab,” said Chad Ray, senior director of Global Therapeutics Research for Zoetis.
For CSU, Goodrich added that the strategic new lab will provide multiple benefits for the campus community and the city of Fort Collins. It also bolsters CSU’s land-grant mission, which includes setting the standard for public research universities in teaching, research, service and extension for the benefit of the citizens of Colorado, the United States and the world.
“The success of our efforts will have the potential to translate into products and services that may greatly improve the health and well-being of farm animals and our agricultural communities,” he said.
About the CSU Research Innovation Center
The Research Innovation Center at CSU is a life-science company accelerator and is home to several startup companies with roots at the university, including SiVEC Biotechnologies LLC, which is developing antiviral applications for the rapid treatment and prevention of avian influenza. The center was originally designed to foster collaborations between private industry and CSU’s academic community. Learn more about the Research Innovation Center at https://www.research.colostate.edu/idrc/research-innovation-center/